Home LiteratureArticle Details
PMID: 2997952 Published · ppublish English Journal Article

Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients--a one-year follow-up.

Transplantation ·Vol. 40 ·No. 5 ·1985-11-00 ·Pages 515-20

Ljungman P, Lönnqvist B, Wahren B, Ringdén O, Gahrton G

Abstract

A group of 46 bone marrow transplant (BMT) recipients were studied by lymphocyte stimulation with cytomegalovirus (CMV) antigen before, and repeatedly in the first year after, BMT. Of these, 25 patients developed CMV infection and 68% of these got a positive lymphocyte response to CMV. The recipients with an early response (up to 3 months) to CMV antigen after the CMV infection were less prone to develop chronic graft-versus-host disease (GVHD) than those who responded later or not at all (P = 0.002). After the CMV infection, the increased lymphocyte CMV reactivity remained in recipients without chronic GVHD, but recipients with chronic GVHD usually lost their reactivity. The results suggest that it may be possible to predict patients who are not going to develop chronic GVHD by studying lymphocyte responses to CMV infections.

MeSH Terms
Antigens, Viral/immunology Bone Marrow Transplantation Cytomegalovirus Infections/immunology Follow-Up Studies Graft vs Host Disease/diagnosis Humans Immunity, Cellular Karyotyping Lymphocyte Activation Lymphocytes/physiology Prognosis Sex Chromosomes/analysis
Chemicals
Antigens, Viral
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Ljungman P
Lönnqvist B
Wahren B
Ringdén O
Gahrton G
Article Info
Journal
Transplantation
Abbr.
Transplantation
ISSN
0041-1337
Published
1985-11-00
Pages
515-20
Language
English
Region
United States
NLM ID
0132144
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]